Clinical outcomes with therapies for previously treated recurrent/metastatic head-and-neck squamous cell carcinoma (R/M HNSCC): A systematic literature review-Reference-Cited by-同舟云学术

Clinical outcomes with therapies for previously treated recurrent/metastatic head-and-neck squamous cell carcinoma (R/M HNSCC): A systematic literature review

Published:2018-09 Issue: Volume:84 Page:108-120
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Lala Mallika,Chirovsky Diana,Cheng Jonathan D.,Mayawala Kapil

Funder

Merck & Co. Inc., Kenilworth, NJ, USA

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference54 articles.

1. Characterization of HPV and host genome interactions in primary head and neck cancers;Parfenov;Proc Natl Acad Sci USA,2014

2. Optimal treatment for recurrent/metastatic head and neck cancer;Vermorken;Ann Oncol,2010

3. Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck;Colevas;J Clin Oncol,2006

4. Head and neck cancer: changing epidemiology, diagnosis, and treatment;Marur;Mayo Clin Proc,2008

5. National Comprehensive Cancer Network, Inc. NCCN Clinical Practice Guidelines. Head and Neck Cancers. Version 1. 2016.

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TTYH3 promotes the malignant progression of oral squamous cell carcinoma SCC-9 cells by regulating tumor-associated macrophage polarization;Archives of Oral Biology;2024-09

2. Identification of splicing factors signature predicting prognosis risk and the mechanistic roles of novel oncogenes in HNSCC;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-04

3. Differential Expression of MicroRNA MiR-145 and MiR-155 Downstream Targets in Oral Cancers Exhibiting Limited Chemotherapy Resistance;International Journal of Molecular Sciences;2024-02-10

4. Immunotherapy for head and neck squamous cell carcinoma: current status and perspectives;Immunotherapy;2024-02

5. Real-world data of immunotherapy from China in recurrent or metastatic head and neck squamous cell carcinoma;American Journal of Otolaryngology;2024-01